Modern is consistent with the literature in this space, but the trial shows that a staged complete procedure might be just ...

The saphenous vein grafts treated in the RCT were relatively straightforward, while the native vessels were largely CTOs.

Having more-thorough workup uncovered an unexpected root cause and changed the treatment course for 76% of patients.

The intracoronary fibrinolysis infusion joins a host of other failed treatments to improve microvascular obstruction after ...

Sahil Parikh and David Cohen discuss the late-breaking trials from day 3.

The data are largely in line with those seen at 5 years, but the follow-up reassures there’s no concern about valve ...

Reaching participants through retail pharmacies, the study speaks to how much VHD goes underrecognized—with a few surprises.

The device, which is delivered transapically, represents an option for very sick patients who previously have had none.

The everolimus scaffold, which had mostly disappeared by 3 years, was still associated with fewer reinterventions than PTA.

The DCB is meant to address long-term stent-related complications and avoid adding yet another metal layer in ISR.

“Cutting balloon angioplasty is a reasonable and less costly option when compared with intravascular lithotripsy for the ...

The first of its kind RCT in acute intermediate-high-risk PE used a surrogate endpoint, but more data are on the horizon.